Holen Sie sich die Stockscreener-App
100.42
2.74%
2.68
Handel nachbörslich:
100.69
0.27
+0.27%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$97.74
Offen:
$97.66
24-Stunden-Volumen:
8.81M
Relative Volume:
0.82
Marktkapitalisierung:
$127.09B
Einnahmen:
$18.44B
Nettoeinkommen (Verlust:
$5.36B
KGV:
24.14
EPS:
4.16
Netto-Cashflow:
$5.41B
1W Leistung:
-3.53%
1M Leistung:
+2.04%
6M Leistung:
+31.37%
1J Leistung:
+31.36%
1-Tages-Spanne:
$97.16
$101.11
1-Wochen-Bereich:
$94.11
$102.69
52-Wochen-Spanne:
$56.32
$108.02
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
100.42 | 122.80B | 18.44B | 5.36B | 5.41B | 4.16 |
|
ASML
Asml Holding Nv
|
753.43 | 285.40B | 34.96B | 10.23B | 10.02B | 26.11 |
|
AMAT
Applied Materials Inc
|
158.24 | 125.53B | 28.61B | 6.83B | 5.82B | 8.39 |
|
KLAC
Kla Corp
|
873.29 | 111.69B | 12.15B | 4.06B | 3.74B | 30.39 |
|
TER
Teradyne Inc
|
119.39 | 19.19B | 2.83B | 469.17M | 568.90M | 2.89 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
OMERS ADMINISTRATION Corp Cuts Position in Lam Research Corporation $LRCX - MarketBeat
Landscape Capital Management L.L.C. Trims Stake in Lam Research Corporation $LRCX - MarketBeat
Kodai Capital Management LP Acquires Shares of 505,987 Lam Research Corporation $LRCX - MarketBeat
Panagora Asset Management Inc. Trims Position in Lam Research Corporation $LRCX - MarketBeat
Is Lam Research Stock Outperforming the Dow? - Yahoo Finance
Vident Advisory LLC Grows Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Trend analysis for Lam Research Corporation this weekQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - Newser
Itau Unibanco Holding S.A. Has $1.54 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Lansforsakringar Fondforvaltning AB publ Sells 8,816 Shares of Lam Research Corporation $LRCX - MarketBeat
When is the best time to exit Lam Research CorporationJuly 2025 Spike Watch & High Return Trade Opportunity Guides - Newser
Trexquant Investment LP Has $52.23 Million Stock Position in Lam Research Corporation $LRCX - MarketBeat
Parnassus Investments LLC Reduces Position in Lam Research Corporation $LRCX - MarketBeat
Jump Financial LLC Lowers Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Multi asset correlation models including Lam Research Corporation2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
Key metrics from Lam Research Corporation’s quarterly dataDividend Hike & Long-Term Growth Plans - Newser
Is Lam Research Corporation stock poised for growthInsider Buying & High Conviction Investment Ideas - Newser
Using Ichimoku Cloud for Lam Research Corporation technicalsJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - Newser
Smart tools for monitoring Lam Research Corporation’s price actionWeekly Investment Report & Fast Moving Trade Plans - Newser
Detecting support and resistance levels for Lam Research CorporationMarket Performance Report & Fast Gain Stock Trading Tips - Newser
What indicators show strength in Lam Research CorporationJuly 2025 Update & Verified Momentum Watchlists - Newser
Erste Group Resumes Coverage of Lam Research (LRCX) Stock with a Buy - Yahoo Finance
How moving averages guide Lam Research Corporation tradingMarket Movement Recap & Free Weekly Watchlist of Top Performers - Newser
Canada Pension Plan Investment Board Buys 1,077,487 Shares of Lam Research Corporation $LRCX - MarketBeat
Momentum divergence signals in Lam Research Corporation chartGap Down & Low Drawdown Momentum Ideas - Newser
Lam Research Corporation (NASDAQ:LRCX) Receives $107.30 Average Target Price from Analysts - MarketBeat
Why Lam Research Stock Crumbled by 3% Today - The Motley Fool
Is now a turning point for Lam Research CorporationDividend Hike & Accurate Entry/Exit Alerts - Newser
Why Lam Research Stock Is Down 3% In Today’s Premarket - Stocktwits
Why Lam Research (LRCX) Stock Is Falling Today - Yahoo Finance
Flputnam Investment Management Co. Purchases 4,823 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Point72 Italy S.r.l. - MarketBeat
Point72 Europe London LLP Lowers Holdings in Lam Research Corporation $LRCX - MarketBeat
US Equipment Makers to See Reduced China Sales Amid Licensing Changes - AInvest
Evergreen Capital Management LLC Purchases 5,130 Shares of Lam Research Corporation $LRCX - MarketBeat
Tema Etfs LLC Grows Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Varadarajan Seshasayee | Senior Vice President |
Feb 20 '25 |
Sale |
90.00 |
110,080 |
9,907,200 |
179,084 |
1.27%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):